Categories
Nuziveedu wins BT Cotton Patent Tussle
Written by Rutuparna Acharya The long battle between Monsanto Co. and Nuziveedu, an Indian Seed Company has come to an end. It was the case of patentability on BT Cotton Seed Varity of Monsanto. Monsanto, an US based Agricultural Company, had secured patent in India over BT Cotton Seed Varieties, Bollgard and Bollgard II in […]
Read more
GOOD NEWS FOR INDIAN START-UPS
Written by: Stuti Raibagkar and Stuti Yagnik It’s now easier for startups from all over world to file a patent in India. The Patent (Amendment) Rules, 2016, an amendment by DIPP (Department of Industrial Policy and Promotion) which have made the startups eligible to get 80% rebate on their patent application fees. This amendment hasn’t […]
Read more
Uber- Alphabet: Tussle for Self-driving Technology
Written by: Stuti Raibagkar Here is one more for the biggest ride hail Company- Uber. It is already dealing with numerous court cases and is facing criticism for its law Enforcement evading software. Now it is faced with one more lawsuit and this relates to Intellectual Property. Alphabet- Google’s parent company has sued Uber for […]
Read more
Indian Salt Gets ‘Nostalgic’ After Big Patent Victory over Unilever
Written By: Rojalin Dhal 85 years ago, India’s greatest freedom fighter, Mahatma Gandhi had initiated the famous revolutionary movement called “Salt Satyagraha” to produce India’s own salt which had paved way for demolishing British monopoly over salt in the Colonial India. The history has once again repeated itself. India has won the Patent war over […]
Read more
It’s Green Signal From USPTO For Google’s Smart Contact Lens
Written By: Rosalin Dhal Innovation knows no boundaries and when there is will (and money :P) to innovate, nobody can stop you. In this techno-freak world, smart gadgets have become an essential part of human sustenance. Forget about touch screen smartphones and solar panels, scientists have developed Invisibility Cloaks that can make even Harry Potter […]
Read more
It’s Déjà vu For Cipla: Patent Office Revokes Another Granted Patent
Written By: Rosalin Dhal Historic Recurrence is a Natural Phenomenon. When Supreme Court cancelled Novartis’ Patent on Glivec, it was clearly a tragedy for the latter and was expected to create a farse for the other branded drug-makers. But no one would have thought that a small hail-ball will groom into a full-fledged snowball so […]
Read more
16192 Coastal Highway, Lewes, Delaware 19958, USA